![J. Marc Simard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. Marc Simard
Directeur/Membre du Conseil chez Remedy Pharmaceuticals, Inc.
Profil
Dr. J.
M.
Simard is on the Board of Directors at Remedy Pharmaceuticals, Inc.
Dr. Simard was previously employed as an Advisory Board Member by Carrot Capital LLC.
He received his undergraduate degree from St. Anselm College and a doctorate degree from Creighton University.
Postes actifs de J. Marc Simard
Sociétés | Poste | Début |
---|---|---|
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Anciens postes connus de J. Marc Simard
Sociétés | Poste | Fin |
---|---|---|
Embark Healthcare
![]() Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Corporate Officer/Principal | - |
Formation de J. Marc Simard
St. Anselm College | Undergraduate Degree |
Creighton University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Embark Healthcare
![]() Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |